Latest news
BioNTech's Founder Exodus and a Halved Ambition: The 16.6 Billion Euro Pivot - AD HOC NEWSAD HOC NEWS · Thu, 06 Aug 2026 19:11:34 GMTBioNTech's 78-Euro Crossroads: A 16.6 Billion Euro Cushion Meets the Post-COVID Reckoning - AD HOC NEWSAD HOC NEWS · Thu, 06 Aug 2026 17:02:58 GMTBioNTech's 79-Euro Question: Can a 16.6 Billion Euro War Chest Outlast the COVID Revenue Cliff? - AD HOC NEWSAD HOC NEWS · Thu, 06 Aug 2026 14:43:22 GMTBioNTech's Pivot Puts a 16.6 Billion Euro Cushion Between the Company and Its Uncertain Future - AD HOC NEWSAD HOC NEWS · Thu, 06 Aug 2026 10:11:35 GMTBioNTech's 16.6 Billion Euro Cushion Faces Its Hardest Test Yet - AD HOC NEWSAD HOC NEWS · Thu, 06 Aug 2026 01:11:46 GMTBioNTech's Transition Math: How Long Can 16.6 Billion Euros Bridge the Gap to Oncology? - AD HOC NEWSAD HOC NEWS · Wed, 05 Aug 2026 18:34:02 GMTAlphabet's Legal Storm Meets Its $514 Billion Answer - AD HOC NEWSAD HOC NEWS · Wed, 05 Aug 2026 14:33:11 GMTVulcan Energy's €2.2 Billion Cushion Can't Stop the Slide Toward Record Lows - AD HOC NEWSAD HOC NEWS · Fri, 31 Jul 2026 19:02:43 GMT